









Markets
/
Stocks
/
nasdaq-unh
/

Unitedhealth Group Inc

UNH

356.600USD

-0.070-0.02%

Close 10/17, 16:00（ET）Quotes delayed by 15 min

322.72BMarket Cap

15.15P/E TTM



Unitedhealth Group Inc

356.600

-0.070-0.02%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Unitedhealth Group Inc

Currency: USD Updated: 2025-10-17

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Unitedhealth Group Inc's Score

Industry at a Glance

Industry Ranking

53 / 72

Overall Ranking

282 / 4691

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 30 analysts

Buy

Current Rating

363.385

Target Price

+1.90%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Unitedhealth Group Inc Highlights

StrengthsRisks

UnitedHealth Group Incorporated is an American multinational for-profit organization that specializes in health insurance and healthcare services, located in Eden Prairie, Minnesota. Operating under the UnitedHealthcare brand for insurance products and the Optum brand for healthcare services, it is recognized as the world's seventh-largest company by revenue and the largest healthcare corporation by revenue. The company ranks 8th on the 2024 Fortune Global 500 list, with a market capitalization of $460.3 billion as of December 20, 2024. UnitedHealth Group has encountered numerous investigations, lawsuits, and penalties—including SEC enforcement related to stock option backdating, Medicare overbilling, unfair claims practices, denials of mental health treatments, and anticompetitive conduct—illuminating deep-rooted issues of fraud, patient harm, and corporate misconduct.

Industry Leader

The company's revenue leads the industry, with the latest annual revenue totaling USD 399.57B.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 23.34% year-on-year.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 52.29%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 52.29%.

Undervalued

The company’s latest PE is 15.34, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 784.16M shares, decreasing 5.56% quarter-over-quarter.

Held by David Tepper

Star Investor David Tepper holds 2.45M shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 1.68.

Financial Health

Currency: USD Updated: 2025-10-17

The company's current financial score is 5.14, which is lower than the Healthcare Providers & Services industry's average of 7.27. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 111.62B, representing a year-over-year increase of 12.91%, while its net profit experienced a year-over-year increase of 19.21%.

Score

Industry at a Glance

Previous score

5.14

Change



Financials

6.07

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

4.94

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

4.88

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

4.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

5.80

Key Metrics

Free cash flow

No Data

Unitedhealth Group Inc's Company Valuation

Currency: USD Updated: 2025-10-17

The company’s current valuation score is 6.55, which is lower than the Healthcare Providers & Services industry's average of 7.12. Its current P/E ratio is 15.34, which is 162.51% below the recent high of 40.26 and 33.19% above the recent low of 10.25.

Score

Industry at a Glance

Previous score

6.55

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 53/72

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-17

The company’s current earnings forecast score is 7.50, which is lower than the Healthcare Providers & Services industry's average of 7.57. The average price target for Unitedhealth Group Inc is 392.50, with a high of 677.00 and a low of 198.00.

Score

Industry at a Glance

Previous score

7.50

Change

Support & Resistance

No Data

Analyst Rating

Based on 30 analysts

Buy

Current Rating

363.385

Target Price

+1.90%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

UnitedHealth Group Inc

UNH

Humana Inc

HUM

Cigna Group

Elevance Health Inc

ELV

Centene Corp

CNC

Molina Healthcare Inc

MOH

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-17

The company’s current price momentum score is 7.34, which is higher than the Healthcare Providers & Services industry's average of 7.21. Sideways: Currently, the stock price is trading between the resistance level at 377.68 and the support level at 334.06, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.34

Change

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(3)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-3.779

Neutral

RSI(14)

57.712

Neutral

STOCH(KDJ)(9,3,3)

26.675

Sell

ATR(14)

9.081

High Vlolatility

CCI(14)

-37.421

Neutral

Williams %R

56.722

Sell

TRIX(12,20)

0.389

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

358.602

Sell

MA10

360.755

Sell

MA20

354.534

Buy

MA50

328.236

Buy

MA100

310.368

Buy

MA200

394.499

Sell

Institutional Confidence

Currency: USD Updated: 2025-10-17

The company’s current institutional recognition score is 7.00, which is lower than the Healthcare Providers & Services industry's average of 7.03. The latest institutional shareholding proportion is 86.58%, representing a quarter-over-quarter decrease of 4.36%. The largest institutional shareholder is The Vanguard, holding a total of 90.50M shares, representing 9.99% of shares outstanding, with 8.52% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

90.50M

-1.42%

BlackRock Institutional Trust Company, N.A.

45.69M

-1.08%

State Street Investment Management (US)

44.93M

-0.91%

Wellington Management Company, LLP

24.21M

-6.32%

Geode Capital Management, L.L.C.

21.31M

+3.27%

T. Rowe Price Associates, Inc.

Star Investors

20.58M

+2.97%

Capital World Investors

18.33M

-19.54%

Capital International Investors

15.75M

-5.39%

Fidelity Management & Research Company LLC

14.48M

-30.95%

Norges Bank Investment Management (NBIM)

12.30M

-2.41%

Risk Assessment

Currency: USD Updated: 2025-10-17

There is no risk assessment score for the company; the Healthcare Providers & Services industry's average is 5.58. The company's beta value is 0.47. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.